SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-24-000067
Filing Date
2024-01-19
Accepted
2024-01-19 16:06:42
Documents
1
Period of Report
2024-01-17

Document Format Files

Seq Description Document Type Size
1 e619197_4-muehler.html 4  
1 e619197_4-muehler.xml 4 4005
  Complete submission text file 0001193805-24-000067.txt   5555
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK CITY NY 10036
Business Address
Muehler Andreas (Reporting) CIK: 0001850468 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 24545635